LAUSR

Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound

Sign Up to like & get
recommendations!
1 Published in 2022 at "Pharmaceutics"

DOI: 10.3390/pharmaceutics14122603

Abstract: Doxorubicin (DOX) is a representative anticancer drug with a unique ability to induce immunogenic cell death of cancer cells. However, undesired toxicity on immune cells has remained a significant challenge, hindering the usage of DOX… read more here.

Keywords: focused ultrasound; combined therapy; ultrasound responsive; evading doxorubicin ... See more keywords